Shares of CareCloud surged 10.1% to $2.56 on August 8 as investors looked past a steep profit decline and focused instead on the healthcare-tech firm's reaffirmed full-year targets and accelerating revenue growth. The stock had fallen to $2.32 after the August 6 earnings release initially spooked traders, but the bounce signals the market is willing to bet on CareCloud's AI pivot — at least for now.

Revenue Is Surging, but Profits Got Cut in Half

Revenue for the quarter totaled $31.9 million, compared with $27.4 million a year earlier — a 16% year-over-year jump marking the ninth consecutive quarter of positive GAAP net income . But that profitability streak is thinning fast: GAAP net income fell to $1.1 million from $2.9 million a year ago, weighed down by AI investments, higher interest expense, and increased costs from acquisitions . Earnings per share came in at breakeven after deducting $941,000 in preferred stock dividends . The gap between top-line momentum and bottom-line erosion is the central tension in this story.

The Preferred-Stock Cleanup Should Free Up Cash

CareCloud completed the redemption of all outstanding Series B preferred stock on May 15, funded through a $50 million credit facility, eliminating roughly $3.3 million in annual preferred dividends without diluting common shareholders . Management said that starting in Q3, a larger share of net income should flow to common shareholders, partially offset by interest costs on the new debt — which it described as meaningfully less expensive than the old preferred obligation . That swap matters: every dollar saved on dividends is a dollar available for AI development or debt reduction.

AI Products Are Signing Deals, but Revenue Proof Is Still Thin

CareCloud's AI-powered front-desk assistant is signing new business, with AI prior-authorization and coding tools on track for market launch . Recurring technology-enabled services now account for about 75% of quarterly revenue, up from 69% a year ago — a mix shift that adds predictability. Yet adjusted EBITDA of $5.9 million was lower than last year, reflecting what the company calls an "investment phase" .

Full-Year Targets Hold the Line

CareCloud reaffirmed FY26 guidance: revenue of $128–$132 million, adjusted EBITDA of $29–$31 million, and GAAP EPS of $0.20 . Free cash flow guidance sits near $25 million . At a market cap around $110 million, the stock trades at roughly 4× that cash-flow target — cheap if the company delivers. But net working capital was just $695,000 as of June 30, despite $13.4 million in cash , leaving little room for execution missteps. The second half must prove AI spending translates into earnings, not just press releases.